The American federal health system has recommended a new shingles vaccine called Shingrix® made by GlaxoSmithKline.
GlaxoSmithKline's shingles vaccine Shingrix won unanimous approval from an advisory panel to the U.S. Food and Drug Administration (FDA), paving the way for the first alternative to Merck's Zostavax.
A group of 18 people from 11 states have filed a lawsuit against Merck & Co. for failing to warn about risks of the Zostavax shingles vaccines.
Merck & Co. is facing a growing number of lawsuits for downplaying the risk of developing shingles and other side effects from the Zostavax shingles vaccine.
After a person who got the vaccine died, health officials in Australia remind doctors not to give Merck's shingles vaccine Zostavax to patients who are sick or on medications that weaken the immune system.